The Chemical Countermeasures Research Program (CCRP) is offering this grant to support vital research aimed at understanding and mitigating the harmful consequences of acute exposure to Ultra-Potent Synthetic (UPS) opioids. This includes substances like fentanyl, carfentanil, nitazenes, and their combinations such as fentanyl with xylazine. This grant is specifically for investigating the immediate deleterious effects as well as the persistent or delayed pathophysiological changes that occur after acute exposure to these powerful agents. The purpose is to foster basic research that can lead to improved countermeasures and treatments against the profound impact of these substances.
Opportunity ID: 357250
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-26-034 |
| Funding Opportunity Title: | Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Use and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 20, 2024 |
| Last Updated Date: | Nov 20, 2024 |
| Original Closing Date for Applications: | Nov 18, 2027 |
| Current Closing Date for Applications: | Nov 18, 2027 |
| Archive Date: | Dec 24, 2027 |
| Estimated Total Program Funding: | $300,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses City or township governments Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities County governments Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-034.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357250 Full Announcement-RFA-DA-26-034 -> RFA-DA-26-034-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288830 | Oct 18, 2025 | Nov 18, 2027 | View |
Package 1
Mandatory forms
357250 RR_SF424_5_0-5.0.pdf
357250 PHS398_CoverPageSupplement_5_0-5.0.pdf
357250 RR_OtherProjectInfo_1_4-1.4.pdf
357250 PerformanceSite_4_0-4.0.pdf
357250 RR_KeyPersonExpanded_4_0-4.0.pdf
357250 PHS398_ResearchPlan_5_0-5.0.pdf
357250 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357250 RR_Budget_3_0-3.0.pdf
357250 RR_SubawardBudget30_3_0-3.0.pdf
357250 PHS398_ModularBudget_1_2-1.2.pdf
357250 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
